slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 17,341-17,370
Pages 819
Rows per page 30
Slide function
17,341-17,370 of 24,547
06
The slide uses a circular diagram to represent the strategy and a list to detail the three focus areas.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses a split-layout design with a dark grey background for the strategy points and a white background for the context callout.HomeStreet | Results Presentation Deck | 36 slides · HomeStreet
Conference presentation Investor relations Beat · Need1 hit
05
Includes technical specifications for three tiers of fuel cell trucks (Short, Medium, Long range).Hyzon | Investor Conference Presentation Deck | 20 slides · Hyzon
Conference presentation Investor relations Beat · Early Struggles1 hit
06
The slide uses a central product image to anchor the comparison between IP metrics on the left and performance metrics on the right.Hyzon | Investor Conference Presentation Deck | 20 slides · Hyzon
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
05
Immix Biopharma | Investor Presentation Deck | 64 slidesImmix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Situation & Context1 hit
06
Includes a biological process diagram showing B-cell development and target markers (CD19, CD20, BCMA).Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations 1 hit
08
Includes flow cytometry plots and bar charts showing efficacy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
10
The slide uses a schematic diagram to map specific protein domains to their functional benefits.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
11
Includes citations from Nature Signal Transduction and Targeted Therapy and Nature Medicine.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
13
The slide highlights the structural advantage of the HSL configuration using a (GGGGS)5 linker.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
17
Includes comparative data points for CAR-T characteristics.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
30
The slide uses a standard pharmaceutical pipeline table format to communicate clinical progress and regulatory milestones.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
38
The slide uses a combination of biological pathway diagrams, pharmacokinetic data, and efficacy metrics to demonstrate the therapeutic advantage of IMX-110.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
42
The slide uses a process flow diagram to illustrate dose escalation steps.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
56
Includes comparative size diagram of IMX-111 vs IgG antibody, bar chart of GLUT1 expression by tissue, box plot of GLUT1 expression by stage, and Kaplan-Meier survival curve.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
58
Includes multiple citations and diagrams of molecular mechanism and clinical trial results.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
60
Immix Biopharma | Investor Presentation Deck | 64 slidesImmix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
61
The slide uses a process-flow style layout to connect platform capabilities to specific product outputs.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
63
The slide uses a 3-pillar framework to categorize the platform's foundation, leading to specific product applications.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
04
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
11
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
17
Uses a before-after framing to demonstrate balance sheet optimization and future resilience.KeyCorp | Results Presentation Deck | 30 slides · KeyCorp
Conference presentation Investor relations Beat · DevelopmentLoop · Before After1 hit
26
The slide uses a circular diagram to map 'Solutions' to 'Applications' in capital markets.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations 1 hit
08
The slide uses a combination of a circular hub-and-spoke style grouping for core strategies and a linear process flow for R&D stages.Legend Biotech | Investor Presentation Deck | 14 slides · Legend Biotech
Conference presentation Investor relations Beat · Solution1 hit
11
The slide details three distinct manufacturing initiatives: the Obelisc facility in Ghent, J&J in-house Lentivirus production, and a CMO partnership with Novartis.Legend Biotech | Investor Presentation Deck | 14 slides · Legend Biotech
Conference presentation Investor relations 1 hit
12
Legend Biotech | Investor Presentation Deck | 14 slidesLegend Biotech | Investor Presentation Deck | 14 slides · Legend Biotech
Conference presentation Investor relations 1 hit
19
The slide uses a flow-based diagram to show asset contributions and equity stakes.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank Beat · The AskLoop · Why Now1 hit
08
The slide illustrates a sequential therapeutic approach: THIO treatment followed by CPI therapy.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
24
The slide highlights both regulatory exclusivity (NCE) and a multi-layered patent strategy extending into the 2040s.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
04
The slide contrasts the company's decentralized approach against centralized CLIA lab competitors.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations 1 hit